Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -192.99% is 176% below its 5-year average of -69.95%, near the low end of its 5-year range (-192.99%–-6.79%).
As of the fiscal period ended Tuesday, March 31, 2026. 69.84% below its 12-month average of -113.64%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -192.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-192.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-113.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-99.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-69.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-69.84%
CURRENT VS 3Y AVG
-94.42%
CURRENT VS 5Y AVG
-175.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.56%
median of 498 covered companies
CURRENT VS SECTOR MEDIAN
-575.75%
vs the sector median at left
Celularity Inc.
Market Cap
$48.63M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-113.64%
3Y Avg
-99.26%
5Y Avg
-69.95%
Market Cap
$50.25M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$49.84M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
Market Cap
$47.64M
Return on Invested Capital (ROIC)
-30.75%
TTM Avg
-66.28%
3Y Avg
-31.28%
5Y Avg
-35.56%
Market Cap
$51.17M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
Market Cap
$51.23M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$45.77M
Return on Invested Capital (ROIC)
-80.92%
TTM Avg
33.73%
3Y Avg
-139.74%
5Y Avg
-139.74%
Market Cap
$51.72M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$51.84M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-130.40%
3Y Avg
-89.09%
5Y Avg
-69.72%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celularity Inc. (CELU) | $48.63M | -192.99% | -113.64% | -99.26% | -69.95% |
| biote Corp. (BTMD)vs › | $50.25M | 13.63% | 32.98% | 9.79% | 24.14% |
| Clene Inc. (CLNN)vs › | $49.84M | -109.13% | -196.06% | -152.48% | -122.21% |
| Lite Strategy, Inc. (LITS)vs › | $47.64M | -30.75% | -66.28% | -31.28% | -35.56% |
| Apollomics, Inc. (APLM)vs › | $51.17M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -157.40% | -135.65% | -123.35% | -111.97% |
| BioStem Technologies, Inc. (BSEM)vs › | $45.77M | -80.92% | 33.73% | -139.74% | -139.74% |
| Envoy Medical, Inc. (COCH)vs › | $51.72M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| INmune Bio, Inc. (INMB)vs › | $51.84M | -96.37% | -130.40% | -89.09% | -69.72% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.71M | N/A | -690.86% | -402.79% | -302.68% |
ROIC
-193.0%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | -192.99% |
| 2025-12-31 | -151.11% |
| 2025-09-30 | -88.81% |
| 2025-06-30 | -81.30% |
| 2025-03-31 | -53.97% |
| 2024-12-31 | -44.94% |
| 2024-09-30 | -16.54% |
| 2024-06-30 | -142.09% |
| 2024-03-31 | -115.50% |
| 2023-12-31 | -166.01% |
| 2023-09-30 | -174.89% |
| 2023-06-30 | -47.67% |
| 2023-03-31 | -14.62% |
| 2022-12-31 | -6.79% |
| 2022-09-30 | -14.25% |
| 2022-06-30 | -10.45% |
| 2022-03-31 | -26.04% |
| 2021-12-31 | -27.90% |
| 2021-09-30 | -19.82% |
| 2021-06-30 | -27.46% |
| 2021-03-31 | -45.73% |
| 2020-12-31 | -37.30% |
| 2020-09-30 | -45.97% |
| 2020-06-30 | -65.26% |
| 2019-12-31 | -6.53% |
